Jan C. Fagerberg

Keine laufenden Positionen mehr

62 Jahre

Health Technology

Consumer Services

Ehemalige bekannte Positionen von Jan C. Fagerberg

Unternehmen	Position	Beginn	Ende
RESPONSE GENETICS, INC	Direktor/Vorstandsmitglied	19.07.2010	12.10.2011
RESPONSE GENETICS, INC	Independent Dir/Board Member	16.07.2010	12.10.2011
TOPOTARGET A/S	Technik-/Wissenschafts-/F&E-Leiter	01.01.2009	01.01.2009
Amgen Rockville, Inc. Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD.	Technik-/Wissenschafts-/F&E-Leiter	19.11.2009	-

Karolinska Institutet

Doctorate Degree

International

Operativ

Sektoral

Health Technology	4
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
RESPONSE GENETICS, INC	Health Technology

Private Unternehmen	2
Amgen Rockville, Inc. Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD.	Health Technology
Topotarget A/S Topotarget A/S Pharmaceuticals: MajorHealth Technology Topotarget A/S is a biotechnology company that is engaged in the development and commercialization of novel drugs for the treatment of cancer. Its product belinostat is a novel histone deacetylase inhibitor which is used for cancer patients. The company was founded by Peter Buhl Jensen and Maxwell Sehested in 2000 and is headquartered in Copenhagen, Denmark.	Health Technology

Private Unternehmen

Health Technology